ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Guoxu Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5231-6590; OpenAlex author ID A5008979274. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Co-assembly of natural small molecules into a carrier-free hydrogel with enhanced synergism for pancreatic cancer theranostic amplification. Last author DOI 10.1016/j.mtbio.2025.101689 ↗
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. Co-author DOI 10.1016/j.canlet.2024.217280 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianzhou Liu · 2 shared papers, 2024–2025 · strength 0.43
- Paper Co-assembly of natural small molecules into a carrier-free hydrogel with enhanced synergism for pancreatic cancer thera… DOI 10.1016/j.mtbio.2025.101689 ↗
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Yong Jin Hou · 1 shared paper, 2025 · strength 0.23
- Paper Co-assembly of natural small molecules into a carrier-free hydrogel with enhanced synergism for pancreatic cancer thera… DOI 10.1016/j.mtbio.2025.101689 ↗
Wenchao Xu · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Bolun Jiang · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Li Zhou · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Qiaofei Liu · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Gary Guishan Xiao · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗
Junchao Guo · 1 shared paper, 2024 · strength 0.20
- Paper Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. DOI 10.1016/j.canlet.2024.217280 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.